SURGE THERAPEUTICS, INC.

Profile

Company Names

SURGE THERAPEUTICS, INC.
STIMIT CORP

Addresses

ONE BROADWAY, 14TH FLOOR, CAMBRIDGE, MA 02142

700 MAIN STREET, CAMBRIDGE, MA 02139

Phone Numbers

617-909-8181

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2016

State Incorporated:

DELAWARE

Total Amount Raised:

$52,638,412.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2023-05-19 
$32,003,969.00 
$49,999,998.00 
$17,996,029.00 
Equity 
1
2020-11-23 
$20,634,443.00 
$29,634,446.00 
$9,000,003.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
CHUCK 
 
CARIGNAN 
EXECUTIVE OFFICER
SURGE THERAPEUTICS, INC.
JASON 
 
COLOMA 
DIRECTOR
ALLOY THERAPEUTICS, INC.   |  SURGE THERAPEUTICS, INC.   |  BIOAGE LABS, INC.   |  EPIBIOLOGICS, INC.   |  OLLIN BIOSCIENCES, INC.
ALI 
 
FARAHANCHI 
DIRECTOR
SURGE THERAPEUTICS, INC.
GARY 
 
GOLDBERG 
EXECUTIVE OFFICER, DIRECTOR
INNROAD INC   |  AMERICAN PIPE + PLASTICS MERGER CORP.   |  SAUGATUCK CAPITAL CO VIII, LLC   |  SAUGATUCK CAPITAL CO IX, LLC   |  SQUADLOCKER, INC.   |  STIMIT CORP   |  SURGE THERAPEUTICS, INC.   |  FRASER ROAD CAPITAL LLC   |  SENTRIMED, INC.
MICHAEL 
 
GOLDBERG 
EXECUTIVE OFFICER, DIRECTOR
IRHYTHM TECHNOLOGIES INC   |  MDV IX LP   |  CRESCENDO BIOSCIENCE, INC.   |  CORVENTIS INC   |  CIVICSOLAR, INC   |  CARDIODX INC   |  ALLIQUA, INC.   |  CORNOVA INC   |  DNANEXUS, INC.   |  COGNOTION, INC.   |  URIGEN PHARMACEUTICALS, INC.   |  MEDITOPE BIOSCIENCES, INC.   |  CAREDX, INC.   |  YOR LABS, INC.   |  STIMIT CORP   |  COUNSLR, INC.   |  MAMS HOLDCO LLC
MICHAEL 
S. 
GOLDBERG 
EXECUTIVE OFFICER, DIRECTOR
SURGE THERAPEUTICS, INC.
ANTONIO 
 
GUALBERTO 
EXECUTIVE OFFICER
KURA ONCOLOGY, INC.   |  KURA OPERATIONS, INC.   |  SURGE THERAPEUTICS, INC.
KOUKI 
 
HARASAKI 
DIRECTOR
ARTIFICIAL, INC.   |  KARLSGATE INC.   |  SURGE THERAPEUTICS, INC.   |  ENSOMA, INC.   |  RECODE THERAPEUTICS, INC.   |  BIOLUMINESCENCE VENTURES FUND I, L.P.   |  BIOLUMINESCENCE VENTURES FUND II, L.P.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2023-06-02
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-05-19 
2020-12-04
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-11-23 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#